Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Sep 30, 2022	Jun 30, 2022
Net Income	-103.12	-79.28	-46.51	-7.27	-7.27
Depreciation & Amortization	3.25	2.31	0.99	0.29	0.29
Stock-Based Compensation	8.97	5.39	3.74	1.09	1.09
Other Adjustments	6.74	21.48	1.95	0.03	0.02
Change in Receivables	0.11	1.05	0.2	0.41	0.41
Changes in Inventories	-	0.01	0.36	-2.67	-2.67
Changes in Accounts Payable	0.15	1.89	1.57	0.24	0.24
Changes in Accrued Expenses	2.01	3.6	1.12	0.14	0.14
Changes in Unearned Revenue	-1.4	28	-	-	-
Changes in Other Operating Activities	0.81	-2.74	-0.33	0.05	0.05
Operating Cash Flow	-82.48	-18.29	-36.91	-7.71	-7.71
Capital Expenditures	-12.75	-54.41	-1.07	-0.27	-0.27
Sale of Property, Plant & Equipment	-	0.34	-	-	-
Purchases of Intangible Assets	-0.14	-0.07	-0.02	-0.02	-0.02
Purchases of Investments	-119.84	-243.51	-	-	-
Proceeds from Sale of Investments	173.95	78.73	22.76	-	-
Payments for Business Acquisitions	-	-	2.7	-	-
Investing Cash Flow	41.23	-218.93	24.37	-0.28	-0.28
Long-Term Debt Repaid	-0.05	-0.05	-0.07	-	-
Net Long-Term Debt Issued (Repaid)	-0.05	-0.05	-0.07	-	-
Issuance of Common Stock	10.36	289.43	0.92	0.06	0.06
Net Common Stock Issued (Repurchased)	10.36	289.43	0.92	0.06	0.06
Other Financing Activities	-	-	-0.07	-	-
Financing Cash Flow	10.31	289.39	0.79	0.06	0.06
Net Cash Flow	-30.95	52.16	-11.76	-7.94	-7.94
Free Cash Flow	-95.23	-72.71	-37.99	-7.98	-7.98
FCF Margin	-10772.96%	-5000.55%	-2648.88%	-73.89%	-
Free Cash Flow Per Share	-1.29	-1.13	-1.42	-0.56	-0.56
Levered Free Cash Flow	-111.1	-100.67	-43.94	-9.5	-9.5
Unlevered Free Cash Flow	-120.62	-109.89	-36.1	-9.62	-8.65

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q